Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
3.680
0.00 (0.00%)
At close: Oct 8, 2025, 4:00 PM EDT
3.680
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:00 PM EDT
IMDX Employees
As of December 31, 2024, Insight Molecular Diagnostics had 49 total employees, including 46 full-time and 3 part-time employees. The number of employees increased by 3 or 6.52% compared to the previous year.
Employees
49
Change (1Y)
3
Growth (1Y)
6.52%
Revenue / Employee
$86,878
Profits / Employee
-$1,294,224
Market Cap
105.32M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 49 | 3 | 6.52% |
Dec 31, 2023 | 46 | -30 | -39.47% |
Dec 31, 2022 | 76 | -39 | -33.91% |
Dec 31, 2021 | 115 | 64 | 125.49% |
Dec 31, 2020 | 51 | 18 | 54.55% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IMDX News
- 2 days ago - iMDx Reports Kidney Transplant Patient Achieved ‘Immune Reset' with Novel Therapy and GraftAssure Monitoring - GlobeNewsWire
- 14 days ago - Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando - GlobeNewsWire
- 4 weeks ago - Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database - GlobeNewsWire
- 4 weeks ago - IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants - GlobeNewsWire
- 6 weeks ago - iMDx to Participate in NYC Investment Conferences September 8 - 11 - GlobeNewsWire
- 2 months ago - IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch - GlobeNewsWire
- 2 months ago - iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference - GlobeNewsWire
- 2 months ago - IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients - GlobeNewsWire